Evolent Health
EVH
69 hedge funds and large institutions have $252M invested in Evolent Health in 2015 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 22 increasing their positions, 15 reducing their positions, and 15 closing their positions.
53% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 15
47% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 15
13% more funds holding
Funds holding: 61 → 69 (+8)
0.98% more ownership
Funds ownership: 37.09% → 38.06% (+0.98%)
13% less capital invested
Capital invested by funds: $288M → $252M (-$36.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.3M |
| 2 |
TCM
TimesSquare Capital Management
New York
|
+$12.1M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$9.93M |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$6.13M |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$3.93M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Carlson Capital
Dallas,
Texas
|
-$8.79M |
| 2 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$8.22M |
| 3 |
Capital Research Global Investors
Los Angeles,
California
|
-$6.83M |
| 4 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
-$6.05M |
| 5 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$4.6M |
EVH Hedge Fund Activity: Q3 2015 in Review
69 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Evolent Health (EVH) for Q3 2015, worth a combined $252M — down 13% from $288M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new EVH positions and 15 closed out — a net gain of 8 holders — while 22 added to existing stakes and 15 trimmed.
The largest buyer was Vanguard Group, adding an estimated $12.3M. The largest seller was Carlson Capital, exiting entirely with an estimated $8.79M sold.
- 69 institutional investors held Evolent Health (EVH) as of Q3 2015, up from 61 in Q2 2015.
- Funds reported $252M of Evolent Health stock for Q3 2015, down 13% quarter-over-quarter.
- 23 funds opened new Evolent Health positions in Q3 2015 and 15 closed out, a net change of +8 holders.
- The largest Evolent Health buyer in Q3 2015 was Vanguard Group, an estimated $12.3M added.
- The largest Evolent Health seller in Q3 2015 was Carlson Capital, an estimated $8.79M sold.
Based on aggregated 13F filings for Q3 2015.